‘Virtual ward’ bed uses 4 times less carbon than traditional inpatient bed

These wards have the potential to reduce need to build more high-carbon impact hospitals A virtual ward bed uses 4 times less carbon than a traditional inpatient bed, so helping the NHS achieve its net zero target by 2045, finds the first study of its kind, published in the open ...

2025-06-18T10:09:50+00:0018 June 2025|BMJ Innovations, Press release|

Cannabis use linked to doubling in risk of cardiovascular disease death

Treat it like tobacco: don’t criminialise it, discourage it, and protect bystanders, says editorial  Cannabis use is linked to a doubling in the risk of dying from cardiovascular disease, with significantly heightened risks of having a stroke or acute coronary syndrome—sudden reduced or blocked blood flow to the heart—finds a ...

2025-06-18T10:06:43+00:0018 June 2025|Heart, Press release|

Despite overall progress, low birthweight rates still high in certain Indian states

Uttar Pradesh, Bihar, Maharashtra, West Bengal account for almost half of all such births Despite overall progress in bringing down low birthweight numbers across India over the past 30 years, rates remain stubbornly high in certain states, with Uttar Pradesh, Bihar, Maharashtra, and West Bengal, accounting for almost half of ...

2025-06-17T11:26:06+00:0017 June 2025|BMJ Global Health, Press release|

Doctors urge FIFA to end deal with Coca-Cola ahead of Club World Cup

“We need to hold these corporate giants accountable for putting profits over public and planetary health,” they argue Football’s governing body FIFA should drop Coca-Cola as sponsors of the 2025 Club World Cup which begins this week, urge doctors in The BMJ today. Dr Chris van Tulleken at University College ...

2025-06-13T08:59:56+00:0013 June 2025|Press release, The BMJ|

Prolonged use of desogestrel pill linked to small increased brain tumour risk

Although risk much lower than some other progestogens and disappeared one year after stopping treatment Taking the progestogen-only contraceptive pill desogestrel continuously for more than five years is associated with a small increased risk of developing a type of brain tumour called an intracranial meningioma, finds a study from France ...

2025-06-12T10:53:44+00:0012 June 2025|Press release, The BMJ|

Doctors raise concern over rise in recreational ketamine use

More individuals are seeking treatment for ketamine addiction Greater awareness, research, and treatments are needed The rise in non-prescribed ketamine use across the UK in recent years is a cause for concern, say doctors in The BMJ today. Irene Guerrini at South London & Maudsley NHS Foundation Trust and colleagues warn that ...

2025-06-12T10:38:40+00:0012 June 2025|Press release, The BMJ|

Over half of doctors surveyed would consider assisted dying if they had advanced cancer or Alzheimer’s disease

And they mostly prefer symptom relief at end of life rather than prolongation of life But preferences vary according to their jurisdiction’s legislation on assisted dying When it comes to advanced cancer or Alzheimer’s disease, over half of doctors would consider assisted dying for themselves, but preferences seem to vary ...

2025-06-11T10:23:56+00:0011 June 2025|Journal of Medical Ethics, Press release|

Urgent need to quantify role of fungal toxins in rising liver cancer rates in Ghana

..to curb global toll taken by the disease, especially in the rest of Africa and Asia High levels of aflatoxin contamination in dietary staples of maize and peanuts With one of the highest rates of liver cancer in Africa, Ghana represents critical case study There’s an urgent need to quantify ...

2025-06-11T10:22:39+00:0011 June 2025|BMJ Global Health, Press release|

P2Y12 drugs may be better than aspirin to prevent heart attack and stroke in patients with coronary artery disease

Findings support use of P2Y12 therapy instead of aspirin for long term prevention Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of cardiovascular death, heart attack and stroke compared with traditional aspirin, with no increased risk of major bleeding, finds a ...

2025-06-06T11:31:20+00:006 June 2025|Press release, The BMJ|

Diabetes drug shows benefits for patients with liver disease

Results support the potential for dapagliflozin to benefit these patients The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical trial from China published by The BMJ today. The results show that treatment with ...

2025-06-06T11:20:55+00:006 June 2025|Press release, The BMJ|
Go to Top